中国食品药品监管2024,Issue(11) :128-133.DOI:10.3969/j.issn.1673-5390.2024.11.014

药品上市许可持有人药物警戒集团化管理研究

Research on the Group-Based Pharmacovigilance Management for Drug Marketing Authorization Holders

席焕鸽
中国食品药品监管2024,Issue(11) :128-133.DOI:10.3969/j.issn.1673-5390.2024.11.014

药品上市许可持有人药物警戒集团化管理研究

Research on the Group-Based Pharmacovigilance Management for Drug Marketing Authorization Holders

席焕鸽1
扫码查看

作者信息

  • 1. 上海市药品和医疗器械不良反应监测中心
  • 折叠

摘要

目的:为药物警戒集团化体系合规运行提供参考.方法:调研具有代表性的集团公司药物警戒工作开展状况,结合药物警戒检查工作,了解药物警戒集团化体系建设情况及特点、药物警戒职责分工落实情况,分析存在的问题等,并提出关于药物警戒集团化体系合规运行及更好地开展药物警戒检查工作的思考与建议.结果与结论:药物警戒集团化管理只有做到合理分工、有序衔接,才有助于资源利用最大化、风险最小化、药物警戒工作合规化.

Abstract

Objective:This study aims to provide a reference for the compliant operation of a group-based pharmacovigilance system.Methods:This research investigates the pharmacovigilance practices of representative pharmaceutical group companies and incorporates insights from pharmacovigilance inspections.It examines the construction and characteristics of group-based pharmacovigilance systems,the implementation of pharmacovigilance responsibilities,and identifies existing issues.Suggestions are provided for ensuring compliant operations within group-based pharmacovigilance systems and improving pharmacovigilance inspection practices.Results and Conclusion:Effective group-based pharmacovigilance management requires a rational division of labor and orderly connection.This approach helps maximize resource utilization,minimize risks,and enhance compliance in pharmacovigilance practices.

关键词

药品上市许可持有人/药物警戒/集团化管理/检查

Key words

marketing authorization holder/pharmacovigilance/group-based management/inspection

引用本文复制引用

出版年

2024
中国食品药品监管
中国医药报社

中国食品药品监管

影响因子:0.099
ISSN:1673-5390
段落导航相关论文